Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells

Virus Research

Volumn 125, Issue 2, 2007, Pages 183-190

  Sauter, Pierre ^a   Lobert, Pierre Emmanuel ^a   Lucas, Bernadette ^a   Varela Calvino, Ruben ^b   Alm, Gunar ^c   Wattre, Pierre ^a   Hober, Didier ^a  

^a University Lille   (France)

^b GUY S HOSPITAL   (United Kingdom)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Coxsackievirus B4; Fusion protein; Peripheral blood mononuclear cells; Plasma; VP4

Indexed keywords

ALPHA INTERFERON; CAPSID PROTEIN; CAPSID PROTEIN VP4; HYBRID PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIBODY DETECTION; ARTICLE; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION;

CAPSID PROTEINS; CARRIER PROTEINS; ENTEROVIRUS B, HUMAN; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; PLASMA;

COXSACKIEVIRUS; ESCHERICHIA COLI; MIRIDAE;

EID: 34247130894     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2007.01.001     Document Type: Article

References (29)

1. Andreoletti L., Hober D., Hober-Vandenberghe C., Belaich S., Vantyghem M.C., Lefebvre J., and Wattre P. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J. Med. Virol. 52 2 (1997) 121-127
2. Bloom M.E., Martin D.A., Oie K.L., Huhtanen M.E., Costello F., Wolfinbarger J.B., Hayes S.F., and Agbandje-McKenna M. Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions. J. Virol. 71 1 (1997) 705-714
3. Böyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. Suppl. 5 (1976) 9-15
4. Brahimi K., Perignon J.L., Bossus M., Gras H., Tartar A., and Druilhe P. Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates. J. Immunol. Methods 162 1 (1993) 69-75
5. Bubeck D., Filman D.J., Cheng N., Steven A.C., Hogle J.M., and Belnap D.M. The structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution reveals the location of an externalized polypeptide that binds to membranes. J. Virol. 79 12 (2005) 7745-7755
6. Chehadeh W., Hober D., Chieux V., Alm G., Harvey J., Lion G., Mouton Y., and Wattre P. Biological properties of IFN-α produced ex-vivo by whole blood of HIV-1 infected patients. Scand. J. Immunol. 49 6 (1999) 660-666
7. Chehadeh W., Weill J., Vantyghem M.C., Alm G., Lefèbvre J., Wattre P., and Hober D. Increased level of IFN-α in blood of insulin-dependent diabetes mellitus patients: relationship with coxsackievirus B infection. J. Infect. Dis. 181 6 (2000) 1929-1939
8. Chehadeh W., Kerr-Conte J., Pattou F., Alm G., Lefebvre J., Wattré P., and Hober D. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol. 74 21 (2000) 10153-10164
9. Chehadeh W., Bouzidi A., Alm G., Wattre P., and Hober D. Human antibodies isolated by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-α by human peripheral blood mononuclear cells in vitro. J. Gen. Virol. 82 Pt 8 (2001) 1899-1907
10. Chehadeh W., Lobert P.E., Sauter P., Goffard A., Lucas B., Hober D., et al. Viral protein VP4 is a target of human antibodies enhancing Coxsackievirus B4- and B3-induced synthesis of alpha interferon. J. Virol. 79 22 (2005) 13882-13891
11. Chung C.T., Niemela S.L., and Miller R.H. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. U.S.A. 86 7 (1989) 2172-2175
12. Danthi P., Tosteson M., Li Q.H., and Chow M. Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus. J. Virol. 77 9 (2003) 5266-5274
13. Feldman S.B., Ferraro M., Zheng H.M., Patel N., Gould-Fogerite S., and Fitzgerald-Bocarsly P. Viral induction of low frequency interferon-alpha producing cells. Virology 204 1 (1994) 1-7
14. Hober D., Chehadeh W., Bouzidi A., and Wattré P. Antibody-dependent of Coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-α synthesis. J. Infect. Dis. 184 9 (2001) 1098-1108
15. Hyoty H., and Taylor T.W. The role of viruses in human diabetes. Diabetologia 45 10 (2002) 1353-1361
16. Kapust R.B., and Waugh D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Prot. Sci. 8 8 (1999) 1668-1674
17. Li Q., Yafal A.G., Lee Y.M., Hogle J., and Chow M. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J. Virol. 68 6 (1994) 3965-3970
18. Paul A.V. Possible unifying mechanism of Picornavirus genome replication. In: Semley B.L., and Wimmer E. (Eds). Molecular Basis of Picornavirus (2002), ASM Press, Washington DC
19. Pitkaranta A., Linnavuori K., Roivainen M., and Hovi T. Induction of interferon-alpha in human leukocytes by polioviruses: wild-type strains are better inducers than attenuated strains. Virology 165 2 (1988) 476-481
20. Pitkaranta A., and Hovi T. Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses. J. Interferon Res. 13 6 (1993) 423-426
21. Roivainen M., Piirainen L., Rysa T., Narvanen A., and Hovi T. An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virology 195 2 (1993) 762-765
22. Rueckert R.R. Picornaviridae: the viruses and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology (1996), Lippincott-Raven, Philadelphia 609-654
23. Stanway G., Hovi T., Knowles N.J., and Hyypiä T. Molecular and biological basis of picornavirus taxonomy. In: Semley B.L., and Wimmer E. (Eds). Molecular Basis of Picornavirus (2002), ASM Press, Washington DC 17-21
24. Svensson H., Cederblad B., Lindahl M., and Alm G. Stimulation of natural interferon-alpha/beta-producing cells by Staphylococcus aureus. J. Interferon Cytokine Res. 16 1 (1996) 7-16
25. Varela-Calvino R., Sgarbi G., Arif S., and Peakman M. T-Cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievrus B4. Virology 274 1 (2000) 56-64
26. Varela-Calvino R., Ellis R., Sgarbi G., Dayan C.M., and Peakman M. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes 51 6 (2002) 1745-1753
27. Varela-Calvino R., and Peakman M. Enteroviruses and type 1 diabetes. Diab. Metab. Res. Rev. 19 6 (2003) 431-441
28. Yin H., Berg A.K., Tuvemo T., and Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51 6 (2002) 1964-1971
29. Yoon J.W., Austin M., Onodera T., and Notkins A.L. Isolation of a virus from the pancreas of child with diabetic ketoacidosis. N. Engl. J. Med. 300 21 (1979) 1173-1179